Fig. 1.
Fig. 1. Prevalences of chronic GVHD (top) and Kaplan-Meier estimates of survival (bottom) in 78 patients with aplastic anemia receiving HLA-identical marrow transplants and GVHD prophylaxis with methotrexate/cyclosporine, 39 of whom were conditioned with CY/ATG (current patients) and 39 received CY alone (historical patients). Tick marks indicate surviving patients.

Prevalences of chronic GVHD (top) and Kaplan-Meier estimates of survival (bottom) in 78 patients with aplastic anemia receiving HLA-identical marrow transplants and GVHD prophylaxis with methotrexate/cyclosporine, 39 of whom were conditioned with CY/ATG (current patients) and 39 received CY alone (historical patients). Tick marks indicate surviving patients.

Close Modal

or Create an Account

Close Modal
Close Modal